More bad news on the recall front for Royal Philips NV, as the U.S. FDA this week categorized the company’s voluntary recall of its Panorama 1.0T HFO open magnetic resonance (MR) system as a class I action. Class I recalls indicate the “use of the devices may cause serious injuries or death,” the FDA noted. Read More
Over the past few years, the health care sector has been progressively leveraging artificial intelligence techniques for activities such as end-to-end drug discovery and development, diagnosing patients, improving communication and engagement between physician and participant, transcribing medical documents and remotely treating and monitoring patients. Read More
With the clock ticking down on 2023, the U.S. FDA seems to be scurrying to push final guidances out the door before the new year. This week, the agency has finalized several guidances, ranging from the use of digital health technology in clinical trials to the use of real-world data (RWD) in drug development. Read More
Vectorious Medical Technologies Ltd. is seeking patent protection for a method for predicting the occurrence of a heart condition by receiving a multiple measurements of blood pressure acquired in a patient’s heart. Read More
Now, in addition to the daily news lineup, you can create topic alerts to be delivered directly to your inbox or via an RSS reader. It’s easy to set up!
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aegis Spine, Claritas, Intelligent Scopes, L&K Biomed, Life Spine, Neuropace. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acclarent. Read More
